Bone Marrow Transplantation in Immunodeficiency Diseases

References

• Rosen F S, Cooper M D, Wedgewood R P. The primary immunodeficiencies. N Engl J Med 1995; 333: 431–40
   PubMed Web of Science ®Google Scholar
• Gatti R A, Meeuwissen H J, Allen H D, Hong R, Good R A. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968; 2: 1366–9
   PubMed Web of Science ®Google Scholar
• Kadowaki J, Thompson R L, Zuelzer W W, et al. XX/XY lymphoid chimerism in congenital immunological deficiency syndrome with thymic alymphocytosis. Lancet 1965; 2: 1152–6
   PubMed Web of Science ®Google Scholar
• Pollack M S, Kirkpatrick D, Kapoor N, O'Reilly R J. Identification by HLA typing of intrauterine-derived maternal T-cells in four patients with severe combined immunodeficiency. N Engl J Med 1982; 307: 662–6
   PubMedGoogle Scholar
• Griscelli C, Durandy A, Virellizier J L, et al. Selective defect of precursor T cells associated with apparently normal B lymphocytes in severe combined immunodeficiency. J Pediatr 1978; 93: 404–11
   PubMed Web of Science ®Google Scholar
• Kenny A B, Hitzig W H. Bone marrow transplantation for severe combined immunodeficiency. Eur J Pediatr 1979; 131: 155–77
   PubMed Web of Science ®Google Scholar
• O'Reilly R J, Brochstein J, Dinsmore R, Kirkpatrick D. Marrow transplantation for congenital disorders. Semin Hematol 1984; 21: 188–213
   PubMedGoogle Scholar
• Fischer A, Friedrich W, Levinsky R, et al. Bone marrow transplantation for immunodeficiencies and osteopetrosis: European survey 1968–1985. Lancet 1986; ii: 1080–3
   Google Scholar
• Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for severe combined immunofeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Blood 1983; 61: 341–8
   PubMed Web of Science ®Google Scholar
• Keever C A, Flomenberg N, Brochstein J, et al. Tolerance of engrafted donor T-cells following bone marrow transplantation for severe combined immunodeficiency. Clin Immunol Immunopathol 1988; 48: 261–76
   PubMedGoogle Scholar
• Reinherz E, Geha R, Rappeport J M, et al. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci USA 1982; 79: 6047–51
   PubMed Web of Science ®Google Scholar
• Friedrich W, Goldmann S F, Vetter U, et al. Immunological reconstitution in severe combined immunodeficiency after transplantation of HLA haploidentical, T cell depleted bone-marrow. Lancet 1984; i: 761–4
   Google Scholar
• Friedrich W, Goldmann S F, Ebell W, et al. Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA haploidentical donors. Eur J Pediatr 1986; 144: 125–30
   Google Scholar
• Buckley R H, Schiff S E, Sampson H A, et al. Development of immunity in human severe primary T-cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986; 136: 2398–407
   PubMedGoogle Scholar
• Cowan M J, Wara D W, Weintrub P S, Pabst H, Ammann A. Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow grafts. J Clin Immunol 1985; 5: 370–6
   PubMedGoogle Scholar
• Fischer A, Durandy A, De Villarty J P, et al. HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E-rosette fractionation and cyclosporine. Blood 1986; 67: 444–9
   PubMed Web of Science ®Google Scholar
• Morgan G, Linen D C, Knott L T, et al. Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T-cell removal using CAMPATH-1 monoclonal antibody and E-rosetting. Br J Haematol 1986; 62: 421–30
   PubMed Web of Science ®Google Scholar
• Fischer A, Landais P, Friedrich W, et al. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 1990; ii: 850–4
   Google Scholar
• O'Reilly R J, Keever C A, Small T N, Brochstein J. The use of HLA-nonidentical T-cell depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodefic Rev 1990; 1: 273–309
   Google Scholar
• Parkman R, Rappeport J, Geha R, et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone marrow transplantation. N Engl J Med 1978; 298: 921–7
   PubMedGoogle Scholar
• Kapoor N, Kirkpatrick D, Blaese R M, et al. Reconstitution of normal megakaryocytopoiesis and immunological functions in Wiskott-Aldrich syndrome by marrow transplantation following myelopablation and immunosuppres-sion with busulfan and cyclophophamide. Blood 1981; 57: 692–6
   PubMed Web of Science ®Google Scholar
• Brochstein J A, Gillio A P, Ruggiero M, et al. Marrow transplantation from human leukocyte antigen identical or haploidentical donors for correction of Wiskott-Aldrich syndrome. J Pediatr 1991; 1: 119–27
   Google Scholar
• Rumelhart S L, Trigg M E, Horowitz S D, Hong D. Monoclonal antibody T-cell depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome. Stood 1990; 75: 1031–5
   Google Scholar
• Fischer A, Landais P, Friedrich W, et al. Bone marrow transplantation in Europe for primary immunodeficiencies other than severe combined immunodeficiency. A report from the European Group for BMT and the European Group for Immunodeficiency. Blood 1994; 4: 1149–54
   Google Scholar
• Thomas C, Le Deist F, Cavazzana-Calvo M, et al. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood 1995; 86: 1629–35
   PubMedGoogle Scholar
• Blanche S, Caniglia M, Girault D, et al. Treatment of hemophagocytic lymphohistiocytosis by chemotherapy and allogeneic bone marrow trans-plantation: a singlecenter study of 22 cases. Blood 1991; 78: 51–4
   PubMed Web of Science ®Google Scholar
• Filipovich A H, Shapiro R S, Ramsey N KC, et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood 1992; 80: 270–6
   PubMed Web of Science ®Google Scholar
• Klein C, Lisowska-Grospierre B, Le Deist B, et al. MHC class II deficiency clinical manifestion, immunological features and evolution in 30 patients. J Pediatr 1993; 123: 921–8
   PubMed Web of Science ®Google Scholar
• Berthet F, Le Deist F, Duliege A M, et al. Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency). Pediatrics 1994; 93: 265–70
   PubMedGoogle Scholar
• Filipovich A H, Blazar B R, Ramsay N KC. Allogeneic bone marrow transplantation for X-linked lymphoproliferative syndrome. Transplantation 1984; 57: 185–208
   Google Scholar
• Virelizier J L, Lagrue A, Durandy A. Reversal of natural killer defect in a patient with Chediak-Higashi syndrome after bone marrow transplantation. N Engl J Med 1982; 306: 1055–6
   PubMedGoogle Scholar
• Rappeport J M, Newburger P E, Goldblum R M, et al. Allogeneic bone marrow transplantation for chronic granulomatous disease. J Pediatr 1982; 101: 951–6
   Google Scholar
• Rappeport J M, Parkmar R, Newburger P, et al. Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. Am J Med 1980; 68: 605–9
   PubMed Web of Science ®Google Scholar
• Gerritsen E JA, Vossen J M, Fasth A, et al. Bone marrow transplantation for autosomal recessive osteopetrosis. J Pediatr 1994; 125: 896–902
   PubMed Web of Science ®Google Scholar
• Coccia P F, Krivit W, Cervenka J. Successful bone marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 1980; 302: 701–8
   PubMed Web of Science ®Google Scholar
• Thomas C, Saint de Basile G, Le Deist F, et al. Brief report. Correction of X-linked hyper IgM syndrome by allogeneic bone marrow transplantation. N Engl J Med 1995; 333: 426–9
   PubMedGoogle Scholar